Pharma advertising hits the mark for news and relevance, but typically disappoints when it comes to being enjoyable. That’s according to Kantar analyst Polly Wyn Jones who recently did a deep dive report on the category after it moved up to become now the second-largest ad spending category.
Pharma jumped ahead of tech brands, and although it still spends less than consumer packaged goods, the category spent an all-time high of $18 billion on advertising in 2023, according to Kantar’s former ad tracking unit Vivvix now owned by MediaRadar.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.